4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

151 filings reported holding FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 39.5M shares of 46.7M outstanding shares and own 84.5% of the company stock.
Largest 10 shareholders include BVF INC/IL (4.63M shares), RA CAPITAL MANAGEMENT, L.P. (4.56M shares), GOLDMAN SACHS GROUP INC (4.13M shares), BlackRock, Inc. (3.87M shares), VANGUARD GROUP INC (2.58M shares), NOVO HOLDINGS A/S (2M shares), JANUS HENDERSON GROUP PLC (1.75M shares), FEDERATED HERMES, INC. (1.59M shares), MILLENNIUM MANAGEMENT LLC (1.15M shares), and ARMISTICE CAPITAL, LLC (1.1M shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.